AGEN · Agenus Inc · Executive Compensation
$6.33
-0.40 (-5.94%)
At close · Nov 16
Return incl. dividend (before tax)
Q2 2025 earnings call transcript
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the timing and completion of these transactions are not entirely within our control, in accordance with applicable accounting standards, substantial doubt exists about our ability to continue as a going concern for at least one year after the filing date of this Quarterly Report on Form 10-Q.”View the 10-Q filed Nov 5, 2026
Market Cap
$304.51M
Shares
45.25M
Volume · Nov 16
319.57K
Avg daily vol (3M)
962.63K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $1,350,325 |
| Steven O’Day | Chief Medical Officer | $902,820 |
| Christine Klaskin | Vice President, Finance | $332,019 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $3,717,621 |
| Steven O’Day | Chief Medical Officer | $968,491 |
| Christine Klaskin | Vice President, Finance | $483,477 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $5,856,319 |
| Steven O’Day | Chief Medical Officer | $1,435,980 |
| Christine Klaskin | Vice President, Finance | $712,747 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $5,626,310 |
| Steven O’Day | Chief Medical Officer | $1,311,248 |
| Christine Klaskin | Vice President, Finance | $628,125 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $9,757,448 |
| Jennifer Buell | Former President and Chief Operating Officer | $7,415,240 |
| Steven O’Day | Chief Medical Officer | $2,372,735 |
| Adam Krauss | Former Chief Legal Officer and Chief Compliance Officer | $875,448 |
| Christine Klaskin | Vice President, Finance | $574,832 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $5,637,244 |
| Jennifer Buell | Former President and Chief Operating Officer | $2,829,910 |
| Evan D. Kearns | Vice President and General Counsel | $923,366 |
| Christine Klaskin | Vice President, Finance | $507,705 |
| Adam Krauss | Former Chief Legal Officer and Chief Compliance Officer | $454,663 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $9,937,038 |
| Jennifer Buell | Former President and Chief Operating Officer | $2,385,369 |
| Jennifer S. Buell | President and Chief Operating Officer | $2,385,369 |
| Evan D. Kearns | Vice President and General Counsel | $1,610,578 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $2,567,842 |
| Jennifer Buell | President and Chief Operating Officer | $986,467 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Marco Tullio Marcucci | Class II director | Appointed | 2026-08-11 |
| Austin Charette | Principal Accounting Officer | Appointed | 2026-01-14 |
| Dr. Garo Armen | interim Chief Financial Officer and Principal Financial Officer | Appointed | 2026-01-14 |
| Ulf Wiinberg | director | Resigned | 2024-11-05 |
| Thomas L. Harrison | Class III director | Appointed | 2024-08-08 |
| Dr. Jennifer Buell | Board of Directors | Appointed | 2024-06-17 |
| Wadih Jordan | director | Resigned | 2022-12-23 |
Leadership
- Garo H. Armen CEO
- Dr. Garo Armen CFO
- Jennifer Buell COO
- Jennifer S. Buell COO
- Austin Charette Chief Accounting Officer
- Dr. Jennifer Buell Board Member
- Marco Tullio Marcucci Board Member
- Paul N. Clark Board Member
- Susan Hirsch Board Member
- Thomas L. Harrison Board Member
Key facts
CIK
1098972
CUSIP
00847G804
13F (30d)
95 filings
82 filers
Visit website
Investor relations